Skip to main content Accessibility help
×
Home

Understanding the severity of depression: do nondepressive symptoms influence global ratings of depression severity?

  • Mark Zimmerman (a1), Caroline Balling (a1), Iwona Chelminski (a1) and Kristy Dalrymple (a1)

Abstract

Objective.

Almost all depression measures have been developed without discussing how to best conceptualize and assess the severity of depression. It is therefore not surprising that measures differ in both how items are rated and item content. The question that we address in the present report from the Rhode Island Methods to Improve Diagnostic Assessment and Services (MIDAS) project is whether a measure of depression severity should include symptoms that are frequent in depressed patients but are defining features of other disorders (eg, anxiety, irritability)

Methods.

Patients were evaluated with a semi-structured interview and severity ratings were made of each symptom of major depressive disorder (MDD) as well as anxiety, irritability, and somatization. Patients were also rated on the Clinical Global Index of severity (CGI).

Results.

Three of the 5 nondepressive symptoms (psychic anxiety, somatic anxiety, and subjective anger) were significantly correlated with the CGI. The correlation between the sum of all 5 nondepressive symptoms and the CGI was significantly lower than the correlation between the sum of the depressive symptom severity ratings (0.12 vs 0.52, z = 11.0, p < .001). The partial correlation between the CGI and the nondepressive symptom severity ratings (after controlling for the total depressive symptom ratings) was nonsignificant.

Discussion.

After accounting for the severity of depressive symptoms, the severity of the nondepressive symptoms was not associated with global ratings of depressive severity. These findings raise questions regarding the appropriateness of including ratings of anxiety, irritability, and somatization on a measure that purportedly assesses the severity of depression.

Copyright

Corresponding author

*Mark Zimmerman, MD, Email: mzimmerman@lifespan.org

References

Hide All
1.Hamilton, M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960; 23(1): 5662.
2.Montgomery, SA, Asberg, M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979; 134(4): 382389.
3.Rush, AJ, Gullion, CM, Basco, MR, Jarrett, RB, Trivedi, MH The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med. 1996; 26(3): 477486.
4.Zimmerman, M, Martin, J, McGonigal, P, et al. Validity of the DSM-5 anxious distress specifier for major depressive disorder. Depress Anxiety. 2019; 36: 3138.
5.Ionescu, DF, Niciu, MJ, Henter, ID, Zarate, CA Defining anxious depression: A review of the literature. CNS Spectr. 2013; 18(5): 252260.
6.Judd, LL, Schettler, PJ, Coryell, W, Akiskal, HS, Fiedorowicz, JG Overt irritability/anger in unipolar major depressive episodes: past and current characteristics and implications for long-term course. JAMA Psychiatry. 2013; 70(11): 11711180.
7.Koh, K, Kim, C, Park, J. Predominance of anger in depressive disorders compared with anxiety disorders and somatoform disorders. J Clin Psychiatry. 2002; 63: 486492.
8.Smith, GR The epidemiology and treatment of depression when it coexists with somatoform disorders, somatization, or pain. Gen Hosp Psychiatry. 1992; 14(4): 265272.
9.Vaccarino, AL, Sills, TL, Evans, KR, Kalali, AH Prevalence and association of somatic symptoms in patients with major depressive disorder. J Affect Disord. 2008; 110(3): 270276.
10.Trivedi, MH, Rush, AJ, Ibrahim, HM, et al. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med. 2004; 34: 7382.
11.Zimmerman, M, Balling, C, Chelminski, I, Dalrymple, K. Understanding the severity of depression: which symptoms of depression are the best indicators of depression severity? Compr Psychiatry. 2018; 87: 8488.
12.Zimmerman, M. A review of 20 years of research on overdiagnosis and underdiagnosis in the Rhode Island Methods to Improve Diagnostic Assessment and Services (MIDAS) Project. Can J Psychiatry. 2016; 61(2): 7179.
13.Zimmerman, M, Mattia, JI Psychiatric diagnosis in clinical practice: Is comorbidity being missed? Compr Psychiatry. 1999; 40: 182191.
14.First, MB, Spitzer, RL, Williams, JBW, Gibbon, M. Structured Clinical Interview for DSM-IV (SCID). Washington, D.C.: American Psychiatric Association; 1997.
15.Endicott, J, Spitzer, RL A diagnostic interview: The Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry. 1978; 35: 837844.
16.Guy, W. NCDEU Assessment Manual for Psychopharmacology. 3rd ed. Rockville, MD: National Institute for Mental Health; 1976.
17.Fava, M, Rankin, MA, Wright, E, et al. Anxiety disorders in major depression. Compr Psychiatry. 2000; 41: 97102.
18.Zimmerman, M, McDermut, W, Mattia, J. The frequency of anxiety disorders in psychiatric outpatients with major depressive disorder. Am J Psychiatry. 2000; 157: 13371400.
19.Coryell, W, Endicott, J, Andreasen, NC, et al. Depression and panic attacks: the significance of overlap as reflected in follow-up and family study data. Am J Psychiatry. 1988; 145: 293300.
20.Gaynes, BN, Magruder, KM, Burns, BJ, Wagner, HR, Yarnall, KSH, Broadhead, WE Does a coexisting anxiety disorder predict persistence of depressive illness in primary care patients with major depression? Gen Hosp Psychiatry. 1999; 21(3): 158167.
21.Lin, CH, Wang, FC, Lin, SC, Chen, CC, Huang, CJ A comparison of inpatients with anxious depression to those with nonanxious depression. Psychiatry Res. 2014; 220(3): 855860.
22.Fichter, MM, Quadflieg, N, Fischer, UC, Kohlboeck, G. Twenty-five-year course and outcome in anxiety and depression in the Upper Bavarian Longitudinal Community Study. Acta Psychiatr Scand. 2010; 122: 7585.
23.Pilkonis, PA, Choi, SW, Reise, SP, Stover, AM, Riley, WT, Cella, D. Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS(R)): depression, anxiety, and anger. Assessment. 2011; 18(3): 263283.
24.Balsamo, M, Giampaglia, G, Saggino, A. Building a new Rasch-based self-report inventory of depression. Neuropsychiatr Dis Treat. 2014; 10: 153165.
25.Vaccarino, AL, Evans, KR, Kalali, AH, et al. The Depression Inventory Development Workgroup: a collaborative, empirically driven initiative to develop a new assessment tool for major depressive disorder. Innov Clin Neurosci. 2016; 13(9-10): 2031.
26.Zimmerman, M. Severity and treatment of depression: a review of 2 controversies. J Nerv Ment Dis, in press.
27.Zimmerman, M, Posternak, MA, Chelminski, I. Symptom severity and exclusion from antidepressant efficacy trials. J Clin Psychopharmacol. 2002; 22(6): 610614.
28.Kotov, R, Krueger, RF, Watson, D, et al. The Hierarchical Taxonomy of Psychopathology (HiTOP): A dimensional alternative to traditional nosologies. J Abnorm Psychol. 2017; 126(4): 454477.
29.Insel, T, Cuthbert, B, Garvey, M, et al. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry. 2010; 167: 748751.

Keywords

Understanding the severity of depression: do nondepressive symptoms influence global ratings of depression severity?

  • Mark Zimmerman (a1), Caroline Balling (a1), Iwona Chelminski (a1) and Kristy Dalrymple (a1)

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed